MAPK8 and chronic obstructive pulmonary disease: Daphnodorin C from D. kiusiana reduced lung inflammation via NF-κB, CREB, JNK, and p38 signaling inhibition and has been suggested as a promising treatment agent for chronic obstructive pulmonary disease [34].